Sexually Transmitted Infections (STIs) Market Report 2026

Sexually Transmitted Infections (STIs) Market Overview

• Sexually Transmitted Infections (STIs) market size has reached to $71.28 billion in 2025 • Expected to grow to $126.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: Government Initiatives Fueling Growth In The Sexually Transmitted Infections (STIS) Market • Market Trend: Innovative Fluorescent Pcr Technology Advancements By Leading Companies In The Sexually Transmitted Infections (STIS) Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sexually Transmitted Infections (STIs) Market?

Sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs), refer to diseases caused by viruses, bacteria and parasites that are passed from one person to another through sexual contact. These infections can be transmitted by vaginal, anal and oral sex and through skin-to-skin contact. The main types of sexually transmitted infections (STIs) are human immunodeficiency virus (HIV), human papillomavirus (HPV); gonorrhea, syphilis and others. Human Immunodeficiency Virus (HIV) is a virus that affects the body's immune system by killing a type of white blood cell that aids in infection resistance. The various treatments are antibiotics and antivirals in various locations of testing such as laboratory testing and point-of-care (POC) testing. The various routes of administration are oral, parenteral and others used in hospitals, specialty clinics, homecare and others.

What Is The Sexually Transmitted Infections (STIs) Market Growth Forecast?

The sexually transmitted infections (stis) market size is expected to see rapid growth in the next few years. It will grow to $126.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to adoption of advanced molecular diagnostics, growth of at-home STI testing, increasing integration with telemedicine platforms, enhanced funding for STI prevention programs, rise of AI-assisted diagnostic tools. Major trends in the forecast period include development of rapid point-of-care STI testing, increasing use of home-based STI test kits, rise in vaccine development for STIs, growing adoption of combination diagnostic platforms, increasing public awareness campaigns for STI prevention.

Global Sexually Transmitted Infections (STIs) Market Segmentation

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types 2) By Treatment: Antibiotics, Antiviral 3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing 4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration 5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments: 1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2 2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV 3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea 4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis 5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

What Is The Driver Of The Sexually Transmitted Infections (STIs) Market?

The surge in government initiatives for spreading awareness of sexually transmitted infections is expected to propel the growth of the sexually transmitted infections (STIs) market going forward. A government initiative is a program or policy implemented to achieve a specific goal and address particular problems. The government offers several initiatives to prevent, control and treat sexually transmitted infections (STIs), such as funds for public education campaigns to raise awareness of STIs, vaccines to prevent certain STIs and free or low-cost screening and testing. For instance, in April 2023, Springfield-Greene County Health, a US-based public health department, announced Disease Intervention Specialist (DIS), a new program and partnership with the Missouri Department of Health and Senior Services (Missouri DHSS) to combat the rising spread of sexually transmitted infections (STIs) in Greene County. The two experts in the DIS program, who will primarily focus on syphilis and HIV, will contact those who test positive for these illnesses, connect them with options for treatment and help identify and get in touch with them to make them aware of the infection. Therefore, the surge in government initiatives will drive the sexually transmitted infections (STIs) industry.

Key Players In The Global Sexually Transmitted Infections (STIs) Market

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

Global Sexually Transmitted Infections (STIs) Market Trends and Insights

Major companies operating in the sexually transmitted infections (STIs) market are developing innovative products with fluorescent PCR technology to gain a competitive advantage in the market. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology technique that detects and quantifies specific DNA sequences in a biological sample. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymer chain reaction (PCR) kits, Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These Kits provide a complete PCR solution for early diagnosis of sexually transmitted illnesses, which impact many individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that uses fluorescent PCR technology to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to detect treponema pallidum nucleic acid in human serum and plasma.

What Are Latest Mergers And Acquisitions In The Sexually Transmitted Infections (STIs) Market?

In February 2023, Caraway Health, a US-based provider of digital healthcare company for Gen Z, partnered with Ash Wellness Inc. for an undisclosed amount. The partnership addresses the surge in sexually transmitted infections (STI) in universities. The collaboration gives Generation Z the tools they require to prioritize sexual well-being on personal terms. Ash Wellness Inc. is a US-based provider of remote diagnostic solutions such as home HIV and STI testing.

Regional Outlook

North America was the largest region in the sexually transmitted infection (STIs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sexually Transmitted Infections (STIs) Market?

The sexually transmitted infections (STIs) market consists of revenues earned by entities by providing services such as treatment, testing, awareness programs and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infections (STIs) market also includes the sales of treatments such as testing kits, vaccines and medication. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sexually Transmitted Infections (STIs) Market Report 2026?

The sexually transmitted infections (stis) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infections (stis) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.